361 results
Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT–FFR trial
16 Aug 2021
The aim of this study was to understand the impact of optical coherence tomography (OCT)-detected thin-cap fibroatheroma (TCFA) on clinical outcomes of diabetes mellitus (DM) patients with fractional flow reserve (FFR)-negative lesions.
Reviewer
Reviewer
Reviewer
In-Stent CTO percutaneous coronary intervention: individual patient data pooled analysis of 4 multicenter registries
12 Aug 2021
This analysis highlights that, in appropriate hands, ISR CTO-PCI is safe, with similar success rates to de-novo CTO-PCI.
Reviewer
Operator volumes and in-hospital outcomes: an analysis of 7,740 rotational atherectomy procedures from the BCIS national database
05 Jul 2021
Find out more about the results of this analysis which suggest that operator experience may be an important effect modifier in ROTA-PCI.
Reviewer
Complications in complex rotational atherectomy
This session will help you get prepared if you have to become familiar with a novel way to release stuck rotational atherectomy burr, deal with severely calcified RCA including removal of a stuck Rotablator, or cope when Rotablator burr catheter entraps.
Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial
18 Jun 2021
The HOST-EXAM trial sought to define whether, after DAPT for PCI with DES, clopidogrel monotherapy is associated with improved outcomes compared with aspirin monotherapy.
Reviewer
External applicability of the ISCHEMIA trial: an analysis of a prospective nationwide registry of patients with stable coronary artery disease
03 Jun 2021
This study aimed to delineate the external validity of the ISCHEMIA trial by applying the ISCHEMIA inclusion and exclusion criteria to an established cohort of patients with stable coronary disease in an observational setting.
Reviewer
Reviewer
Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis
01 Jun 2021
The value of elective coronary revascularisation plus medical therapy over medical therapy alone in managing stable patients with coronary artery disease is debated. Hence, the authors reviewed all trials comparing the two strategies in this population to appraise whether revascularisation in addition to medical therapy affects...
Reviewer
Meta-analysis of elective coronary revascularization versus medical therapy alone - EuroPCR 2021 interview
27 May 2021 – From EuroPCR 2021
Luis Ortega Paz interviews Eliano Navarese, lead investigator of this meta-analysis of elective coronary revascularization versus medical therapy alone, released as a late-breaking trial at EuroPCR 2021:
- The gap in evidence that motivated this systematic review and meta-analysis
- The methodology employed
- The main findings
- How will these results impact clinical...
EuroPCR 2021 Hotlines / Late-Breaking Trials: Alster-FLX, ANGIE, COLOR, CREDENCE BRS, and P3
27 May 2021 – From EuroPCR 2021
Find out more about various studies & registries:
- Left atrial appendage occlusion with the WATCHMAN FLX: The Alster-FLX Registry
- Anatomical snuffbox for coronary angiography and interventions
- Randomized comparison between Radial and Femoral Large-bore access Complex PCI
- Experience with BRS for treatment of de novo native peripheral artery lesions
- Clinical validation of...
EuroPCR 2021 Hotlines / Late-Breaking Trials in physiology: FAST II, TARGET FFR, P3, OLV Pullback, France PCI, and more!
27 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in imaging:
- Angiography based Fractional Flow Reserve: the FAST II trial
- Instantaneous wave-free ratio for the assessment of nonculprit lesions
- Capacity of the PPG to predict functional revascularisation
- Clinical impact of FFR guided PCI
